Literature DB >> 8871006

Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate.

T M Illidge1, M Hussey, C W Godden.   

Abstract

A patient is reported who was found to have metastatic breast cancer in pregnancy. Intravenous pamidronate was given with beneficial effect in the third trimester. There were no serious adverse effects on the foetus.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8871006     DOI： 10.1016/s0936-6555(05)80667-3

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


  12 in total

1.  Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health.

Authors:  S R Mastaglia; N P Watman; B Oliveri
Journal:  Osteoporos Int       Date:  2010-06-10       Impact factor: 4.507

Review 2.  Osteoporosis in juvenile idiopathic arthritis--a practical approach to diagnosis and therapy.

Authors:  Johannes Roth; Susanne Bechtold; Gudrun Borte; Frank Dressler; Hermann J Girschick; Michael Borte
Journal:  Eur J Pediatr       Date:  2007-04-14       Impact factor: 3.183

Review 3.  Osteoporosis in young adults: pathophysiology, diagnosis, and management.

Authors:  S Ferrari; M L Bianchi; J A Eisman; A J Foldes; S Adami; D A Wahl; J J Stepan; M-C de Vernejoul; J-M Kaufman
Journal:  Osteoporos Int       Date:  2012-06-09       Impact factor: 4.507

Review 4.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

5.  Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists.

Authors:  Sophie E McGrath; Alistair Ring
Journal:  Ther Adv Med Oncol       Date:  2011-03       Impact factor: 8.168

6.  Pamidronate Administration During Pregnancy and Lactation Induces Temporal Preservation of Maternal Bone Mass in a Mouse Model of Osteogenesis Imperfecta.

Authors:  Diana Olvera; Rachel Stolzenfeld; Emily Fisher; Bonnie Nolan; Michelle S Caird; Kenneth M Kozloff
Journal:  J Bone Miner Res       Date:  2019-10-09       Impact factor: 6.741

Review 7.  Taking bisphosphonates during pregnancy.

Authors:  Amy E French; Nikolay Kaplan; Michael Lishner; Gideon Koren
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

8.  Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases.

Authors:  Yuzaburo Inoue; Naoki Shimojo; Shuichi Suzuki; Takayasu Arima; Minako Tomiita; Masanori Minagawa; Yoichi Kohno
Journal:  Clin Rheumatol       Date:  2008-03-11       Impact factor: 2.980

Review 9.  Treatment of premenopausal women with low bone mineral density.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Curr Osteoporos Rep       Date:  2008-03       Impact factor: 5.096

10.  [Diagnosis, prophylaxis and therapy of osteoporosis in juvenile idiopathic arthritis: consensus statement of the German Association for Pediatric Rheumatology].

Authors:  J Roth; S Bechtold; G Borte; F Dressler; H Girschick; M Borte
Journal:  Z Rheumatol       Date:  2007-09       Impact factor: 1.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.